Healio

4% tetrasodium EDTA decreases central venous access device complications in ICU

ICU patients with a central venous access device had a smaller incidence rate of device-related complications with 4% ...
EurekAlert!

New study adds to evidence on best CVAD securement methodology

FERNDALE, Mich. -- A new study on securement for central vascular access devices (CVAD) suggests that subcutaneous anchor securement systems (SASS) are shown to be more effective at keeping central ...
Medical Dialogues

4 Perent Tetrasodium EDTA Locking Solution Reduces Central Venous Catheter Complications in ICU Patients: Study

Canada: Researchers have discovered in a new study that among adult intensive care unit (ICU) patients, the use of 4% tetrasodium EDTA (t-EDTA) as a central venous access device (CVAD) locking ...
ascopubs.org

Epidemiology and natural history of central venous access device (CVAD) use and infusion pump performance among patients (pts) treated for metastatic colorectal cancer (mCRC ...

A pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy based on capecitabine: Polymorphisms in thymidilyate synthase and DNA repair genes. This is an ASCO ...
FierceBiotech

Abiomed snags CE mark for Impella cVAD heart pump

EU surgeons will also be able to use the device as a cardiovascular support system during coronary bypass surgery. The Danvers, MA-based company describes the Impella cVAD as being designed to give " ...
TCTMD

MIRVAD (Mitral Repair Under Ventricular Assist Device): A Planned cVAD Strategy for High-Risk Secondary Mitral TEER

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...